Table 2.
Characteristics of preventive studies (n = 66).
| Characteristics of study | Ayurveda (n = 43) | Yoga & Naturopathy (n = 1) | Unani (n = 4) | Siddha (n = 2) | Homeopathy (n = 9) | Others (n = 3) | Collaborative (n = 4) |
|---|---|---|---|---|---|---|---|
| Study arms | |||||||
| Single arm | 16 | 0 | 0 | 0 | 3 | 1 | 2 |
| Double arm | 26 | 1 | 2 | 2 | 5 | 2 | 2 |
| Multi arm | 1 | 0 | 2 | 0 | 1 | 0 | 0 |
| Sample size | |||||||
| ≤30 | 3 | 0 | 0 | 0 | 1 | 1 | 0 |
| 31–100 | 6 | 1 | 1 | 0 | 0 | 0 | 1 |
| 101–1000 | 17 | 0 | 1 | 0 | 4 | 2 | 3 |
| >1001 | 17 | 0 | 2 | 2 | 4 | 0 | 0 |
| Study Population | |||||||
| Healthy volunteers | 7 | 0 | 0 | 0 | 1 | 0 | 1 |
| High Risk Individuals | 36 | 1 | 4 | 2 | 8 | 3 | 3 |
| Type of Intervention (where applicable) | |||||||
| Single drug formulation | 16 | 0 | 0 | 0 | 4 | 1 | 0 |
| Multi drug formulation | 13 | 0 | 1 | 1 | 2 | 1 | 0 |
| Multi-formulation regime | 14 | 0 | 3 | 1 | 3 | 1 | 3 |
| Non-Pharmacological | 0 | 1 | 0 | 0 | 0 | 0 | 1 |
| Use of comparators | |||||||
| AYUSH vs. CCa | 16 | 0 | 2 | 2 | 0 | 1 | 2 |
| AYUSH vs. Placebo/No Treatment | 7 | 1 | 2 | 0 | 5 | 1 | 0 |
| AYUSH vs. nutritional/ | 2 | 0 | 0 | 0 | 1 | 0 | 0 |
| dietary items | |||||||
| AYUSH + CC vs.CC or Placebo + CC | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Treatment duration | |||||||
| ≤7 days | 1 | 0 | 0 | 0 | 3 | 0 | 0 |
| >7 days to ≤15 days | 1 | 0 | 2 | 1 | 1 | 2 | 1 |
| >15 days to ≤30 days | 17 | 0 | 1 | 0 | 0 | 1 | 0 |
| >30 days | 12 | 0 | 0 | 0 | 1 | 0 | 2 |
| Not Specified | 12 | 1 | 1 | 1 | 4 | 0 | 1 |
| Primary Outcomes | |||||||
| Incidence of infection | 38 | 1 | 4 | 2 | 9 | 3 | 4 |
| Incidence of infection & AYUSH specific parameters | 4 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acceptability of Intervention | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Study Duration | |||||||
| ≤3 months | 20 | 1 | 2 | 0 | 4 | 0 | 1 |
| >3 moths & ≤ 6 months | 15 | 0 | 2 | 2 | 5 | 3 | 1 |
| >6 months & ≤ 1 year | 6 | 0 | 0 | 0 | 0 | 0 | 2 |
| >1 year | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
CC: Conventional Care.